Found 5 results

↓ CSV
Name Type of Offering Accepted Date
Nacuity Pharmaceuticals, Inc. See All Filings
D 2016-12-08 17:15:38
Amount To Be Raised $2,500,000
Associated Brokers / Dealers N/A
CIK Number 0001690279
Filed Document 0001250853-16-000186
Exclusions or Exemptions 506b
Accepted Date 2016-12-08 17:15:38
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings
D 2017-06-27 15:04:43
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001690279
Filed Document 0001250853-17-000059
Exclusions or Exemptions 506b
Accepted Date 2017-06-27 15:04:43
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings
D/A 2017-07-20 16:17:38
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001690279
Filed Document 0001250853-17-000065
Exclusions or Exemptions 506b
Accepted Date 2017-07-20 16:17:38
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings
D/A 2022-01-03 16:28:34
Amount To Be Raised $17,400,000
Associated Brokers / Dealers N/A
CIK Number 0001690279
Filed Document 0001690279-22-000001
Exclusions or Exemptions 506b
Accepted Date 2022-01-03 16:28:34
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings
D 2021-03-30 13:33:03
Amount To Be Raised $11,000,000
Associated Brokers / Dealers N/A
CIK Number 0001690279
Filed Document 0001690279-21-000003
Exclusions or Exemptions 506b
Accepted Date 2021-03-30 13:33:03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity